2496 — Wuhan YZY Biopharma Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$911.09m
- HK$912.24m
- CNY107.81m
Annual balance sheet for Wuhan YZY Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 103 | 201 | 197 | 126 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.328 | 0.337 | 16.2 | 58.1 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 126 | 239 | 250 | 221 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 60.1 | 54.7 | 50.5 | 45.5 |
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Total Assets | 200 | 303 | 302 | 268 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 56.9 | 147 | 174 | 186 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 57 | 147 | 174 | 237 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 143 | 156 | 128 | 30.5 |
| Total Liabilities & Shareholders' Equity | 200 | 303 | 302 | 268 |
| Total Common Shares Outstanding |